NCT04931641View on ClinicalTrials.gov

Potential of Prebiotic Galacto-oligosaccharides in Improving Efficacy and Safety of Oral Iron Supplementation in HIV-infected Children

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

October 4, 2022

Study Completion Date

October 4, 2022

Conditions
Iron DeficiencyHIV
Interventions
DIETARY_SUPPLEMENT

Galacto-oligosaccharides

Prebiotic galacto-oligosaccharides (GOS)

OTHER

Maltodextrin

Maltodextrin (placebo)

DIETARY_SUPPLEMENT

Ferrous fumarate

50 mg iron as ferrous fumarate

Trial Locations (1)

Unknown

Familiy Clinical Research Unit (FAMCRU), Cape Town

All Listed Sponsors
collaborator

University of Stellenbosch

OTHER

lead

Swiss Federal Institute of Technology

OTHER

NCT04931641 - Potential of Prebiotic Galacto-oligosaccharides in Improving Efficacy and Safety of Oral Iron Supplementation in HIV-infected Children | Biotech Hunter | Biotech Hunter